Rui Moreira completed his master degree in Pharmaceutical Sciences at the Faculty of Pharmacy, University of Lisbon, and obtained his PhD in Pharmacy under supervision of Professors Eduarda Rosa (University of Lisbon) and Jim Iley (The Open University, UK). After a postdoctoral stay in the UK, where he worked on prodrug chemistry from a physical organic chemistry point of view, Rui started his career as an independent scientist at the Faculty of Pharmacy, University of Lisbon. He was promoted to Full Professor of Medicinal Chemistry in 2006. Rui’s research is focused on chemical tools to study the underlying mechanisms in infectious diseases, cancer and neurodegenerative disorders. His current research interests cover the development of anti-infectious agents, prodrug chemistry and targeted drug delivery systems, design of covalent inhibitors, and design of chemical probes for activity- and photoaffinity-based protein profiling. He has published over 150 papers (SCOPUS AUTHOR ID 71025540 and ORCID ID 0000-0003-0727-9852) and supervised/co-supervised more than 20 PhD students. Rui was co-founder of the Medicinal Chemistry Division of the Portuguese Chemical Society, and as served EFMC as Council member in 2008-2015 and as Executive Committee member since 2015. He is the current EFMC President.